Table 2

Comparison of cytogenetic and molecular response rates in the IRIS and TIDEL trials at 12 months and 24 months

Major cytogenetic response (0%-35% Ph+)Complete cytogenetic response (0% Ph+)Major molecular response (≤ 0.1% BCR-ABL [IS])
Response rate at 12 months    
    TIDEL 90 (85-96)* 88 (82-94)* 47 (37-56)* 
    IRIS 85 (81-88)* 69% (65-74)* 40 (36-44)* 
    P for z test .101 < .001 .214 
Response rate at 24 months    
    TIDEL 91 (86-96)* 90 (85-95)* 73 (62-84)* 
    IRIS 90 (86-93)* 80 (76-84)* 55 (NA) 
    P for z test .682 .002 NA 
Major cytogenetic response (0%-35% Ph+)Complete cytogenetic response (0% Ph+)Major molecular response (≤ 0.1% BCR-ABL [IS])
Response rate at 12 months    
    TIDEL 90 (85-96)* 88 (82-94)* 47 (37-56)* 
    IRIS 85 (81-88)* 69% (65-74)* 40 (36-44)* 
    P for z test .101 < .001 .214 
Response rate at 24 months    
    TIDEL 91 (86-96)* 90 (85-95)* 73 (62-84)* 
    IRIS 90 (86-93)* 80 (76-84)* 55 (NA) 
    P for z test .682 .002 NA 

IRIS figures for MCR and CCR are based on the 5-year update.13  MMR rate at 24 months in IRIS based on European Haematology Association abstract in Haematologica. 2005;90[Suppl 2]:48.

NA indicates not available.

*

Percentage achieving response (95% confidence intervals).

Close Modal

or Create an Account

Close Modal
Close Modal